Please assess the completion status of the following clinical trial:

Trial Title: Open Trial Determining Antidepressant Effects of Omega-3 Supplementation During Pregnancy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Women with uncomplicated pregnancy within the 1st or 2nd trimester of pregnancy~2. Score of 10 or greater on the nine item Patient Health Questionnaire (PHQ-9) for depression~Exclusion Criteria:~1. antidepressant use in preceding month~2. use in previous 4 weeks of psychotropic medications other than hypnotics or benzodiazepines in diazepam dose-equivalents greater than or equal to 2mg/day for insomnia~3. Fish allergy~4. initiation of regularly scheduled course of psychotherapy within previous 2 months

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Supplementation (Type: EXPERIMENTAL): Subjects received Omega-3 PUFA supplementation

Based on this trial design, predict the completion outcome and termination type (if applicable).